Atlas Trials

Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma

Clinical trial NCT02667886 · COMPLETED

Trial details

NCT number
NCT02667886
Sponsor
X4 Pharmaceuticals
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Clear Cell Renal Cell Carcinoma
Start date
2016-04-27
Primary completion
2022-04-14
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.